ES556663A0 - Procedimiento para preparar derivados de alcoholes primarios de halogeno-bifenil metilo. - Google Patents

Procedimiento para preparar derivados de alcoholes primarios de halogeno-bifenil metilo.

Info

Publication number
ES556663A0
ES556663A0 ES556663A ES556663A ES556663A0 ES 556663 A0 ES556663 A0 ES 556663A0 ES 556663 A ES556663 A ES 556663A ES 556663 A ES556663 A ES 556663A ES 556663 A0 ES556663 A0 ES 556663A0
Authority
ES
Spain
Prior art keywords
procedure
primary alcohol
alcohol derivatives
image
preparing halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES556663A
Other languages
English (en)
Other versions
ES8802294A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of ES556663A0 publication Critical patent/ES556663A0/es
Publication of ES8802294A1 publication Critical patent/ES8802294A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14Unsaturated ethers
    • C07C43/17Unsaturated ethers containing halogen
    • C07C43/174Unsaturated ethers containing halogen containing six-membered aromatic rings
    • C07C43/1742Unsaturated ethers containing halogen containing six-membered aromatic rings with halogen atoms bound to the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES556663A 1985-07-08 1986-06-25 Procedimiento para preparar derivados de alcoholes primarios de halogeno-bifenil metilo. Expired ES8802294A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8510528A FR2584403B1 (fr) 1985-07-08 1985-07-08 Derives d'alcools primaires halogeno biphenyles utiles en therapeutique dans le traitement de l'atherosclerose

Publications (2)

Publication Number Publication Date
ES556663A0 true ES556663A0 (es) 1988-05-01
ES8802294A1 ES8802294A1 (es) 1988-05-01

Family

ID=9321137

Family Applications (4)

Application Number Title Priority Date Filing Date
ES556663A Expired ES8802294A1 (es) 1985-07-08 1986-06-25 Procedimiento para preparar derivados de alcoholes primarios de halogeno-bifenil metilo.
ES557813A Expired ES8802217A1 (es) 1985-07-08 1988-01-29 Procedimiento para preparar esteres de alcohol primario de halogeno-bifenilmetanol
ES557811A Expired ES8802215A1 (es) 1985-07-08 1988-01-29 Procedimiento para preparar derivados de alcoholes primarios de halogeno-bifenilmetilo
ES557812A Expired ES8802216A1 (es) 1985-07-08 1988-01-29 Procedimiento para preparar derivados de alcoholes primarios de halogeno-bifenil-4-metanol

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES557813A Expired ES8802217A1 (es) 1985-07-08 1988-01-29 Procedimiento para preparar esteres de alcohol primario de halogeno-bifenilmetanol
ES557811A Expired ES8802215A1 (es) 1985-07-08 1988-01-29 Procedimiento para preparar derivados de alcoholes primarios de halogeno-bifenilmetilo
ES557812A Expired ES8802216A1 (es) 1985-07-08 1988-01-29 Procedimiento para preparar derivados de alcoholes primarios de halogeno-bifenil-4-metanol

Country Status (10)

Country Link
US (1) US4734417A (es)
EP (1) EP0210885B1 (es)
JP (1) JPS6210032A (es)
AT (1) ATE54445T1 (es)
AU (1) AU590295B2 (es)
CA (1) CA1270831A (es)
DE (1) DE3672538D1 (es)
ES (4) ES8802294A1 (es)
FR (1) FR2584403B1 (es)
ZA (1) ZA865075B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753262A (en) * 1995-06-07 1998-05-19 Aronex Pharmaceuticals, Inc. Cationic lipid acid salt of 3beta N- (N', N'-dimethylaminoethane) - carbamoyl!cholestrol and halogenated solvent-free preliposomal lyophilate thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2527963A (en) * 1948-06-16 1950-10-31 Parke Davis & Co beta-dimethylamino-ethyl rho-halobenzhydryl ethers and their salts
US3624142A (en) * 1964-09-10 1971-11-30 Merck & Co Inc Substituted biphenyl acetic acid derivatives
DE2328973A1 (de) * 1973-06-07 1975-01-02 Thomae Gmbh Dr K Neue biphenyl-derivate
DE2330838A1 (de) * 1973-06-16 1975-01-09 Thomae Gmbh Dr K Neue carbonsaeureester von 3-(4biphenylyl)-1-butanolen und 3-(4-biphenylyl)2-buten-1-olen
FR2476072A1 (fr) * 1980-02-18 1981-08-21 Fabre Sa Pierre Phenyl-4 benzoate de nicotinamido methyle, nouveaux derives utiles en therapeutique comme normolipemiants choleretiques
FR2498449A1 (fr) * 1981-01-23 1982-07-30 Fabre Sa Pierre Acides halogeno biphenyl carboxyliques et leurs sels utiles en therapeutique
JPS6011483A (ja) * 1983-06-29 1985-01-21 Taiho Yakuhin Kogyo Kk ピペラジン化合物

Also Published As

Publication number Publication date
AU5982186A (en) 1987-01-15
EP0210885B1 (fr) 1990-07-11
ES8802217A1 (es) 1988-04-16
ES557813A0 (es) 1988-04-16
ES557811A0 (es) 1988-04-16
AU590295B2 (en) 1989-11-02
ES8802215A1 (es) 1988-04-16
CA1270831A (fr) 1990-06-26
FR2584403B1 (fr) 1987-10-23
ES8802216A1 (es) 1988-04-16
EP0210885A1 (fr) 1987-02-04
ES557812A0 (es) 1988-04-16
FR2584403A1 (fr) 1987-01-09
ZA865075B (en) 1987-02-25
ATE54445T1 (de) 1990-07-15
ES8802294A1 (es) 1988-05-01
JPS6210032A (ja) 1987-01-19
DE3672538D1 (de) 1990-08-16
US4734417A (en) 1988-03-29

Similar Documents

Publication Publication Date Title
ES509848A0 (es) "procedimiento para la preparacion de nuevos derivados de la aminometil-5-aril-3-oxazolidinona-2-"
ES545842A0 (es) Procedimiento para preparar difosfonatos
ES545145A0 (es) Procedimiento para la preparacion de nuevos compuestos fluo-roalcoxilicos
ES2079719T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su utilizacion y agentes que los contienen en calidad de anticoagulantes.
AR231441A1 (es) Procedimiento para la preparacion de compuestos aminados de la piridazina
ES515613A0 (es) "un procedimiento para la preparacion de derivados de s-adenosilmetionina".
ES521086A0 (es) Procedimiento para la preparacion de imidazolilfenil-tetrahidropiridazinas.
ES554305A0 (es) Procedimiento para la fabricacion de derivados quinolilglicinamidas
ES556663A0 (es) Procedimiento para preparar derivados de alcoholes primarios de halogeno-bifenil metilo.
ES520024A0 (es) Procedimiento para la obtencion de nuevas piridazinonas.
ES538982A0 (es) Procedimiento para obtencion de un preparado farmaceutico para tratamiento terapeutico de enfermedades reumaticas.
MX155561A (es) Procedimiento para la obtencion de derivados de fenetanolamina
ES545004A0 (es) Un procedimiento para producir un acetileno.
ES536991A0 (es) Procedimiento para la preparacion de un derivado de 4-alquil-2-hidroxi-3-metil-2-fenil-morfolina
ES555030A0 (es) Procedimiento para la obtencion de nuevos derivados de isoxazol
AR223223A1 (es) Procedimiento para la preparacion de bis-(p-(i-etoxi-etoxi)fenil)-2-piridilmetano(i)
ES497948A0 (es) Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2)sustituidas
MX9206685A (es) Procedimiento para la preparacion de adipatos de alquilo
ES8307242A1 (es) Un procedimiento para la preparacion de 3(2-(3-alquil y alquenil-4-piperidil))indoles.
ES501744A0 (es) Procedimiento para la obtencion de bis (fenoxiacetatos sus- tituidos)de n-alcohil-dialcanolaminas
ATE36697T1 (de) Tertiaere halogenierte biphenylalkohole die nuetzlich in der therapeutik bei der behandlung von atheriosklerose sind.
ES265185Y (es) "quemador de excrementos para aprovechamiento termico de los mismos".
MX154896A (es) Procedimiento para la preparacion de sales de s-adenosil-metionina estables
AR228390A1 (es) Procedimiento para la preparacion de derivados de 2-(pirrol-1-il)-4-aminobutiramida
ES503916A0 (es) Por procedimiento para la preparacion de derivados de 4-hi- droxi-tetrahidropiran-2-ona